Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Myeloperoxidase antibody (FITC)

This Mouse Monoclonal antibody specifically detects Myeloperoxidase in FACS. It exhibits reactivity toward Human and has been mentioned in 2+ publications.
Catalog No. ABIN2475784

Quick Overview for Myeloperoxidase antibody (FITC) (ABIN2475784)

Target

See all Myeloperoxidase (MPO) Antibodies
Myeloperoxidase (MPO)

Reactivity

  • 185
  • 66
  • 58
  • 8
  • 4
  • 3
  • 3
  • 1
  • 1
  • 1
Human

Host

  • 147
  • 91
  • 1
  • 1
  • 1
Mouse

Clonality

  • 134
  • 107
Monoclonal

Conjugate

  • 124
  • 30
  • 28
  • 10
  • 9
  • 9
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This Myeloperoxidase antibody is conjugated to FITC

Application

  • 146
  • 94
  • 88
  • 60
  • 56
  • 52
  • 36
  • 19
  • 16
  • 14
  • 14
  • 13
  • 10
  • 7
  • 6
  • 5
  • 5
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
Flow Cytometry (FACS)

Clone

2C7
  • Characteristics

    Purified IgG conjugated to Fluorescein Isothiocyanate Isomer 1 (FITC)

    Isotype

    IgG1
  • Application Notes

    Optimal working dilution should be determined by the investigator.

    Restrictions

    For Research Use only
  • Format

    Liquid

    Concentration

    0.1 mg/mL
  • Zhang, Van Zele, Perez-Novo, Van Bruaene, Holtappels, DeRuyck, Van Cauwenberge, Bachert: "Different types of T-effector cells orchestrate mucosal inflammation in chronic sinus disease." in: The Journal of allergy and clinical immunology, Vol. 122, Issue 5, pp. 961-8, (2008) (PubMed).

    Patry, Nachman, Audrain, Falk, Meflah, Esnault: "Difference in antigenic determinant profiles between human and rat myeloperoxidase." in: Clinical and experimental immunology, Vol. 132, Issue 3, pp. 505-8, (2003) (PubMed).

  • Target

    Myeloperoxidase (MPO)

    Alternative Name

    MYELOPEROXIDASE

    Gene ID

    4353

    UniProt

    P05164

    Pathways

    Chromatin Binding
You are here:
Chat with us!